Philip D Harvey

发表

Impact of genotyping errors on statistical power of association tests in genomic analyses: A case study

Kei-Hoi Cheung, Hongyu Zhao, Lin Hou, 2017, Genetic epidemiology.

Temporal characteristics of tract-specific anisotropy abnormalities in schizophrenia

Patrick R Hof, Cheuk Y. Tang, Philip D. Harvey, 2008, Neuroreport.

A double blind placebo controlled trial of donepezil adjunctive treatment to risperidone for the cognitive impairment of schizophrenia

Philip D. Harvey, Philip D Harvey, J. Friedman, 2002, Biological Psychiatry.

Validating measures of real-world outcome: the results of the VALERO expert survey and RAND panel.

Philip D. Harvey, Philip D Harvey, Robert K Heaton, 2011, Schizophrenia bulletin.

Practice effects due to serial cognitive assessment: Implications for preclinical Alzheimer's disease randomized controlled trials

Philip D. Harvey, Philip D Harvey, Lon S Schneider, 2015, Alzheimer's & dementia.

Negative symptoms and cognitive deficits: what is the nature of their relationship?

Philip D. Harvey, Philip D Harvey, A. Reichenberg, 2006, Schizophrenia bulletin.

Circumstances Under Which Practice Does Not Make Perfect: A Review of the Practice Effect Literature in Schizophrenia and Its Relevance to Clinical Treatment Studies

Philip D. Harvey, Philip D Harvey, Delbert G Robinson, 2010, Neuropsychopharmacology.

Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients.

Patrick R Hof, Cheuk Y. Tang, Philip D. Harvey, 2008, The American journal of psychiatry.

The Validation of a Caregiver Assessment of Dementia: The Dementia Severity Scale

Philip D. Harvey, Philip D Harvey, Karin Coyne, 2005, Alzheimer disease and associated disorders.

The genetics of functional disability in schizophrenia and bipolar illness: Methods and initial results for VA cooperative study #572

Hongyu Zhao, Mary Brophy, Philip D. Harvey, 2014, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Cognition in schizophrenia: impairments, determinants, and functional importance.

Philip D. Harvey, Philip D Harvey, C. Bowie, 2005, The Psychiatric clinics of North America.

Neuropsychological impairments in schizophrenia: Integration of performance-based and brain imaging findings.

Philip D. Harvey, Philip D Harvey, A. Reichenberg, 2007, Psychological bulletin.

Convergence of Different Versions of the Continuous Performance Test: Clinical and Scientific Implications

Philip D. Harvey, Philip D Harvey, D. Pogge, 2003, Journal of clinical and experimental neuropsychology.

Hypofrontality in unmedicated schizophrenia patients studied with PET during performance of a serial verbal learning task

Igor Nenadic, Philip D. Harvey, Philip D Harvey, 2000, Schizophrenia Research.

Characterizing affective instability in borderline personality disorder.

Philip D. Harvey, Philip D Harvey, Larry J Siever, 2002, The American journal of psychiatry.

Outcomes Assessment in Clinical Trials of Alzheimer's Disease and its Precursors: Readying for Short-term and Long-term Clinical Trial Needs.

Philip D. Harvey, Philip D Harvey, Keith Wesnes, 2017, Innovations in clinical neuroscience.

Catechol-O-methyltransferase Val158Met genotype variation is associated with prefrontal-dependent task performance in schizotypal personality disorder patients and comparison groups

David Goldman, Philip D. Harvey, Philip D Harvey, 2006, Psychiatric genetics.

Changes in relative glucose metabolic rate following cortisol administration in aging veterans with posttraumatic stress disorder: an FDG-PET neuroimaging study.

Philip D. Harvey, Philip D Harvey, Randall E Newmark, 2009, The Journal of neuropsychiatry and clinical neurosciences.

Is schizophrenia a syndrome of accelerated aging?

Philip D. Harvey, Philip D Harvey, Brian Kirkpatrick, 2008, Schizophrenia bulletin.

Implementation considerations for multisite clinical trials with cognitive neuroscience tasks.

Philip D. Harvey, Philip D Harvey, R. Keefe, 2007, Schizophrenia bulletin.

Cognitive functioning in schizophrenia: a consensus statement on its role in the definition and evaluation of effective treatments for the illness.

Michael F. Green, Philip D. Harvey, Philip D Harvey, 2004, The Journal of clinical psychiatry.

Social Cognition Psychometric Evaluation: Results of the Final Validation Study

Philip D. Harvey, Philip D Harvey, D. Penn, 2018, Schizophrenia bulletin.

Cross-national cognitive assessment in schizophrenia clinical trials: a feasibility study

Philip D. Harvey, Philip D Harvey, G. Smedt, 2003, Schizophrenia Research.

Improvement in cognitive function following a switch to ziprasidone from conventional antipsychotics, olanzapine, or risperidone in outpatients with schizophrenia

Steven G Potkin, Philip D. Harvey, Philip D Harvey, 2004, Schizophrenia Research.

The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery

Philip D. Harvey, Philip D Harvey, James M Gold, 2004, Schizophrenia Research.

Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new take on an old problem.

Philip D. Harvey, Philip D Harvey, Dwight Dickinson, 2009, Schizophrenia bulletin.

Cognitive and functional changes with aging in schizophrenia

William Byne, Philip D. Harvey, Philip D Harvey, 1999, Biological Psychiatry.

Premorbid Intellectual Functioning and Risk of Schizophrenia and Spectrum Disorders

Asaf Caspi, Mark Weiser, Philip D. Harvey, 2006, Journal of clinical and experimental neuropsychology.

Enhanced Effects of Cortisol Administration on Episodic and Working Memory in Aging Veterans with PTSD

Philip D. Harvey, Philip D Harvey, M. Buchsbaum, 2007, Neuropsychopharmacology.